Ambiq와 ThinkAR, AR 안경 산업 혁신 위해 AiLens 출시
PB 텍사스 오스틴, Jan. 08, 2025 (GLOBE NEWSWIRE) — 엣지 AI를 구현하는 초저전력 반도체와 솔루션을 개발하는 선도 기업 Ambiq®가 증강현실(AR)과 AI…
Read MoreJanuary 2025
Ambiq 和 ThinkAR 联袂推出 AiLens， 颠覆 AR 眼镜行业
得克萨斯州奥斯汀, Jan. 08, 2025 (GLOBE NEWSWIRE) — 领先的超低功耗半导体和边缘 AI 解决方案开发商 Ambiq® 与增强现实 (AR) 和 AI 技术先驱 ThinkAR 强强联合，推出专为日常佩戴设计的超轻便智能眼镜 AiLens。 AiLens…
Read MoreAmbiq e ThinkAR Revolucionam Indústria de Óculos de Realidade Aumentada com o AiLens
AUSTIN, Texas, Jan. 08, 2025 (GLOBE NEWSWIRE) — A Ambiq®, desenvolvedora líder de semicondutores e soluções de potência ultrabaixa que…
Read MoreStreamline Your Customer Service with MiiTel and Deskpro Integration
The integration of MiiTel and Deskpro allows companies to efficiently manage customer interactions across calls, WhatsApp chats, and the ticketing…
Read MoreBamboo Rose acquiert Verteego et lance la première plateforme d’intelligence décisionnelle alimentée par l’IA dans le secteur de la vente au détail
PRNewswire BOSTON, 8 janvier 2025 /PRNewswire/ — Bamboo Rose, le chef de file des solutions de gestion de la vente au…
Read MoreKuehn Law Encourages Investors of Progyny, Inc. to Contact Law Firm
NEW YORK, Jan. 7, 2025 /PRNewswire/ — Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers…
Read MoreKuehn Law Encourages Investors of Syndax Pharmaceuticals, Inc. to Contact Law Firm
NEW YORK, Jan. 7, 2025 /PRNewswire/ — Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers…
Read MoreWOLF SHAREHOLDER ALERT: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Wolfspeed, Inc.
RADNOR, Pa., Jan. 7, 2025 /PRNewswire/ — The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors…
Read MoreCentific to Redefine AI-Powered Video Intelligence Using NVIDIA AI
Leveraging NVIDIA Metropolis, NVIDIA NeMo Retriever, and NIM microservices, Centific’s frontier AI data foundry transforms complex video data into actionable…
Read MoreEyebright Medical recibe el certificado NMPA Clase III por su lente intraocular fáquica
HONG KONG, 8 de enero de 2025 /PRNewswire/ — Eyebright Medical Technology (Beijing) Co., Ltd. (“Eyebright Medical“, la “Compañía“, Código…
Read More